Expression of its ligand PD-L1 by tumor cells can lead to engagement of PD-1 on tumor-reactive T cells, which in turn are silenced though this inhibitory interaction, consequently leading to immune evasion. This evidence concerns the gene PDCD1 and neoplasm.